PRTN3 and rheumatoid arthritis: The strong indications of T cell involvement in ACPA+ RA, and the clinical and molecular differences between ACPA+ and ACPA− disease, prompted us to investigate differences in Th cell populations between ACPA+ and ACPA− RA patients.